Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Carbapenem-Based Antibiotics Global Market Report 2025
Download Free Sample Buy Now
Global Carbapenem-Based Antibiotics Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Carbapenem-Based Antibiotics Global Market Report 2025

By Type (Meropenem, Imipenem, Doripenem, Tebipenem, Other Types), By Indication (Intra-abdominal Infections, Urinary Tract Infections, Pneumonia, Bacterial Meningitis, Skin and Skin Structure Infections, Acute Pelvic Infections, Prophylaxis of Surgical Site Infection, Respiratory Tract Infections, Gynecological Infections, Other Indications ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Carbapenem-Based Antibiotics Market Overview

• Carbapenem-Based Antibiotics market size has reached to $4.6 billion in 2024

• Expected to grow to $5.97 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%

• Growth Driver: Rising Bacterial Infections And The Surge In Demand For Carbapenem-Based Antibiotics Is A Driving Force In Market Expansion

• Market Trend: Innovative Product Launches Drive Growth In The Carbapenem-Based Antibiotics Market

• North America was the largest region in 2024.

What Is Covered Under Carbapenem-Based Antibiotics Market?

Carbapenem-based antibiotics are a class of broad-spectrum antibiotics that are highly effective against many bacterial infections. Carbapenem antibiotics are commonly used to treat severe infections caused by gram-positive and gram-negative bacteria, including some strains resistant to other antibiotics.

The main types of carbapenem-based antibiotics are meropenem, imipenem, doripenem, tebipenem, and others. Meropenem is a broad-spectrum antibiotic used to treat a wide range of bacterial infections by inhibiting bacterial cell wall synthesis. Meropenem is used to treat a variety of serious bacterial infections, including pneumonia, meningitis, intra-abdominal infections, urinary tract infections, and skin and soft tissue infections. The carbapenem-based antibiotics are used to treat intra-abdominal infections, urinary tract infections, pneumonia, bacterial meningitis, Skin And Skin Structure Infections, acute pelvic infections, prophylaxis of surgical site infection, respiratory tract infections, gynecologic infections, and others that are sold in hospital pharmacies, retail pharmacies, and online pharmacies.

Carbapenem-Based Antibiotics Market Size and growth rate 2025 to 2029: Graph

What Is The Carbapenem-Based Antibiotics Market Size 2025 And Growth Rate?

The carbapenem-based antibiotics market size has grown steadily in recent years. It will grow from $4.6 billion in 2024 to $4.78 billion in 2025 at a compound annual growth rate (CAGR) of 3.8%. The growth in the historic period can be attributed to epidemics and pandemics, rise in chronic diseases, healthcare infrastructure growth, rapid urbanization, natural disasters and health emergencies

What Is The Carbapenem-Based Antibiotics Market Growth Forecast?

The carbapenem-based antibiotics market size is expected to see strong growth in the next few years. It will grow to $5.97 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increased incidence of hospital-acquired infections, emergence of multi-drug resistant strains, growing aging population, rise in surgical procedures, proliferation of infectious diseases, changing demographics. Major trends in the forecast period include supply chain resilience and security, alternative treatment development, shift towards outpatient settings, growing awareness on antimicrobial stewardship, precision medicine approaches.

The forecast of 5.7% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. infectious disease departments by inflating prices of carbapenem-based antibiotics developed in Italy and Japan, resulting in limited multidrug-resistant infection treatment options and higher antimicrobial stewardship program costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Carbapenem-Based Antibiotics Market Segmented?

1) By Type: Meropenem, Imipenem, Doripenem, Tebipenem, Other Types

2) By Indication: Intra-abdominal Infections, Urinary Tract Infections, Pneumonia, Bacterial Meningitis, Skin And Skin Structure Infections, Acute Pelvic Infections, Prophylaxis of Surgical Site Infection, Respiratory Tract Infections, Gynecological Infections, Other Indications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Meropenem: Meropenem Injection, Meropenem and Vaborbactam Combination, Meropenem for Pediatric Use

2) By Imipenem: Imipenem and Cilastatin Combination, Imipenem and Relebactam Combination, Imipenem Monotherapy

3) By Doripenem: Doripenem Injection, Doripenem for Complicated Infections

4) By Tebipenem: Tebipenem for Oral Administration, Tebipenem Pediatric Formulations, Tebipenem for Resistant Infections

5) By Other Types: Ertapenem, Panipenem, Faropenem, Combinations with Beta-Lactamase Inhibitors

What Is Driving The Carbapenem-Based Antibiotics Market? Rising Bacterial Infections And The Surge In Demand For Carbapenem-Based Antibiotics Is A Driving Force In Market Expansion

The increasing incidence of bacterial infections is expected to propel the growth of the carbapenem-based antibiotics market going forward. Bacterial infections are infections caused by bacteria, microscopic organisms that can invade the body and cause a range of diseases and symptoms. Carbapenem-based antibiotics treat severe or multidrug-resistant bacterial infections, including those caused by gram-positive and gram-negative bacteria. For instance, in July 2024, according to the report published by the Centers for Disease Control and Prevention, a US-based government agency, during 2023, 78% of all bacterial infections were diagnosed by CIDTs in the historic catchment area, including 46% diagnosed using only CIDTs. Therefore, an increased incidence of bacterial infections drives the growth of the carbapenem-based antibiotics industry.

What Is Driving The Carbapenem-Based Antibiotics Market? Surge In Surgical Procedures Fuels Growth Of The Carbapenem-Based Antibiotics Market

The increasing number of surgical procedures is expected to propel the growth of the carbapenem-based antibiotics market going forward. Surgical procedures refer to medical interventions performed by a qualified surgeon to treat, repair, remove, or replace a part of the body that may be affected by disease, or injury. Carbapenems offer a broad spectrum of activity, effective against infections in the abdominal cavity, combat infections, reduce the need for combination therapy, simplifying treatment regimens in surgical patients, and effective in the treatment of meningitis. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based organization, aesthetic procedures reached nearly 35 million in 2023, with the total number of surgical and non-surgical procedures rising by 3.4% to 34.9 million. Therefore, the increasing number of surgical procedures is driving the growth of the carbapenem-based antibiotics industry.

Who Are The Major Players In The Global Carbapenem-Based Antibiotics Market?

Major companies operating in the carbapenem-based antibiotics market include Pfizer Inc., Merck & Co. Inc., Fresenius Kabi LLC, GlaxoSmithKline Plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Meiji Holdings Co. Ltd., Sandoz International GmbH, Sumitomo Dainippon Pharma Co. Ltd., Shionogi & Co Ltd., Aurobindo Pharma Ltd., Acurx Pharmaceuticals LLC, Daewoong Pharmaceutical Co. Ltd., CeramTec GmbH, ACS Dobfar S.p.A, JW Pharmaceutical Corp, Centrient Pharmaceuticals Co, Spero Therapeutics Inc., Kopran Limited, Savior Lifetec Corporation, Flagship Biotech International Pvt. Ltd., Iterum Therapeutics plc, Cam Carbapenem-based antibiotics BV, Intelicure Lifesciences, Ikeda Corporation

What Are The Key Trends Of The Global Carbapenem-Based Antibiotics Market? Innovative Product Launches Drive Growth In The Carbapenem-Based Antibiotics Market

Product Innovations are the key trend gaining popularity in the carbapenem-based antibiotics market. Major companies operating in the carbapenem-based antibiotics market are innovating products to sustain their position in the market. For instance, in August 2024, according to the National Health Service, a UK-based Government department, launched a pioneering subscription scheme for antibiotics in collaboration with the pharmaceutical sector to combat antimicrobial resistance (AMR). Announced on August 12, 2024, this innovative model allows drugmakers to receive fixed annual fees—up to £20 million per drug—regardless of the volume prescribed, thus removing incentives for overuse. The scheme is valued at approximately £1.9 billion over 16 years and aims to encourage the development of new antibiotics by ensuring financial viability for pharmaceutical companies. This initiative follows a successful pilot phase and is part of the UK’s broader strategy to tackle AMR, which poses a significant global health threat, potentially leading to millions of deaths by 2050 if left unaddressed. The NHS will prioritize products targeting critical pathogens identified by the World Health Organization, reinforcing its commitment to responsible antibiotic stewardship while fostering innovation in antibiotic development.

What Are The Key Trends Of The Global Carbapenem-Based Antibiotics Market? Pfizer's Investment In Spero Therapeutics Boosts Global Expansion Of Carbapenem-Based Antibiotics

Major companies operating in the carbapenem-based antibiotics market are focusing on investments to drive revenues in their market. For instance, in September 2024, Hikma Pharmaceuticals, a US-based pharmaceutical company, launched Clindamycin Injection in 5% Dextrose in the United States, offering a new treatment option for serious bacterial infections caused by susceptible gram-positive bacteria. Available in ready-to-use 50 mL containers with dosages of 600 mg and 900 mg, this injectable antibiotic is particularly beneficial for patients allergic to penicillin. The introduction of this product enhances treatment options for healthcare providers managing complex infections, such as respiratory and skin infections, while reinforcing Hikma's commitment to addressing antibiotic resistance and improving patient care through accessible medication solutions.

Need data on a specific region in this market?
Request Regional Data

Carbapenem-Based Antibiotics Market Merger And Acquisition: GSK PLC Secures Exclusive License For Tebipenem HBR From Spero Therapeutics Inc

In September 2022, GSK PLC, a UK-based pharmaceutical and biotechnology company, and Spero Therapeutics, Inc. entered into an exclusive license agreement for $66 million upfront, with the potential for future milestone payments and tiered royalties. The exclusive license allows GSK to commercialize tebipenem HBr in all regions except for Japan and certain other Asian countries. Spero Therapeutics is a US-based clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments and medicine for bacterial infections, including multi-drug resistant and rare diseases, including carbapenem oral antibiotic.

Regional Outlook For The Global Carbapenem-Based Antibiotics Market

North America was the largest region in the Carbapenem-Based Antibiotics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Carbapenem-Based Antibiotics Market?

The carbapenem-based antibiotics market consists of sales of imipenem-cilastatin, meropenem, ertapenem, doripenem, biapenem, panipenem, tebipenem, razupenem, tomopenem, and faropenem. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Carbapenem-Based Antibiotics Industry?

The carbapenem-based antibiotics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the carbapenem-based antibiotics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Carbapenem-Based Antibiotics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $4.78 billion
Revenue Forecast In 2034 $5.97 billion
Growth Rate CAGR of 5.7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Meropenem, Imipenem, Doripenem, Tebipenem, Other Types
2) By Indication: Intra-abdominal Infections, Urinary Tract Infections, Pneumonia, Bacterial Meningitis, Skin And Skin Structure Infections, Acute Pelvic Infections, Prophylaxis of Surgical Site Infection, Respiratory Tract Infections, Gynecological Infections, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Meropenem: Meropenem Injection, Meropenem and Vaborbactam Combination, Meropenem for Pediatric Use
2) By Imipenem: Imipenem and Cilastatin Combination, Imipenem and Relebactam Combination, Imipenem Monotherapy
3) By Doripenem: Doripenem Injection, Doripenem for Complicated Infections
4) By Tebipenem: Tebipenem for Oral Administration, Tebipenem Pediatric Formulations, Tebipenem for Resistant Infections
5) By Other Types: Ertapenem, Panipenem, Faropenem, Combinations with Beta-Lactamase Inhibitors
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Merck & Co. Inc., Fresenius Kabi LLC, GlaxoSmithKline Plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Meiji Holdings Co. Ltd., Sandoz International GmbH, Sumitomo Dainippon Pharma Co. Ltd., Shionogi & Co Ltd., Aurobindo Pharma Ltd., Acurx Pharmaceuticals LLC, Daewoong Pharmaceutical Co. Ltd., CeramTec GmbH, ACS Dobfar S.p.A, JW Pharmaceutical Corp, Centrient Pharmaceuticals Co, Spero Therapeutics Inc., Kopran Limited, Savior Lifetec Corporation, Flagship Biotech International Pvt. Ltd., Iterum Therapeutics plc, Cam Carbapenem-based antibiotics BV, Intelicure Lifesciences, Ikeda Corporation
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Carbapenem-Based Antibiotics Market Characteristics

3. Carbapenem-Based Antibiotics Market Trends And Strategies

4. Carbapenem-Based Antibiotics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Carbapenem-Based Antibiotics Growth Analysis And Strategic Analysis Framework

5.1. Global Carbapenem-Based Antibiotics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Carbapenem-Based Antibiotics Market Growth Rate Analysis

5.4. Global Carbapenem-Based Antibiotics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Carbapenem-Based Antibiotics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Carbapenem-Based Antibiotics Total Addressable Market (TAM)

6. Carbapenem-Based Antibiotics Market Segmentation

6.1. Global Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Meropenem

Imipenem

Doripenem

Tebipenem

Other Types

6.2. Global Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intra-abdominal Infections

Urinary Tract Infections

Pneumonia

Bacterial Meningitis

Skin And Skin Structure Infections

Acute Pelvic Infections

Prophylaxis of Surgical Site Infection

Respiratory Tract Infections

Gynecological Infections

Other Indications

6.3. Global Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

6.4. Global Carbapenem-Based Antibiotics Market, Sub-Segmentation Of Meropenem, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Meropenem Injection

Meropenem and Vaborbactam Combination

Meropenem for Pediatric Use

6.5. Global Carbapenem-Based Antibiotics Market, Sub-Segmentation Of Imipenem, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Imipenem and Cilastatin Combination

Imipenem and Relebactam Combination

Imipenem Monotherapy

6.6. Global Carbapenem-Based Antibiotics Market, Sub-Segmentation Of Doripenem, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Doripenem Injection

Doripenem for Complicated Infections

6.7. Global Carbapenem-Based Antibiotics Market, Sub-Segmentation Of Tebipenem, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tebipenem for Oral Administration

Tebipenem Pediatric Formulations

Tebipenem for Resistant Infections

6.8. Global Carbapenem-Based Antibiotics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ertapenem

Panipenem

Faropenem

Combinations with Beta-Lactamase Inhibitors

7. Carbapenem-Based Antibiotics Market Regional And Country Analysis

7.1. Global Carbapenem-Based Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Carbapenem-Based Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Carbapenem-Based Antibiotics Market

8.1. Asia-Pacific Carbapenem-Based Antibiotics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Carbapenem-Based Antibiotics Market

9.1. China Carbapenem-Based Antibiotics Market Overview

9.2. China Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Carbapenem-Based Antibiotics Market

10.1. India Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Carbapenem-Based Antibiotics Market

11.1. Japan Carbapenem-Based Antibiotics Market Overview

11.2. Japan Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Carbapenem-Based Antibiotics Market

12.1. Australia Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Carbapenem-Based Antibiotics Market

13.1. Indonesia Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Carbapenem-Based Antibiotics Market

14.1. South Korea Carbapenem-Based Antibiotics Market Overview

14.2. South Korea Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Carbapenem-Based Antibiotics Market

15.1. Western Europe Carbapenem-Based Antibiotics Market Overview

15.2. Western Europe Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Carbapenem-Based Antibiotics Market

16.1. UK Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Carbapenem-Based Antibiotics Market

17.1. Germany Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Carbapenem-Based Antibiotics Market

18.1. France Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Carbapenem-Based Antibiotics Market

19.1. Italy Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Carbapenem-Based Antibiotics Market

20.1. Spain Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Carbapenem-Based Antibiotics Market

21.1. Eastern Europe Carbapenem-Based Antibiotics Market Overview

21.2. Eastern Europe Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Carbapenem-Based Antibiotics Market

22.1. Russia Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Carbapenem-Based Antibiotics Market

23.1. North America Carbapenem-Based Antibiotics Market Overview

23.2. North America Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Carbapenem-Based Antibiotics Market

24.1. USA Carbapenem-Based Antibiotics Market Overview

24.2. USA Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Carbapenem-Based Antibiotics Market

25.1. Canada Carbapenem-Based Antibiotics Market Overview

25.2. Canada Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Carbapenem-Based Antibiotics Market

26.1. South America Carbapenem-Based Antibiotics Market Overview

26.2. South America Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Carbapenem-Based Antibiotics Market

27.1. Brazil Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Carbapenem-Based Antibiotics Market

28.1. Middle East Carbapenem-Based Antibiotics Market Overview

28.2. Middle East Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Carbapenem-Based Antibiotics Market

29.1. Africa Carbapenem-Based Antibiotics Market Overview

29.2. Africa Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Carbapenem-Based Antibiotics Market Competitive Landscape And Company Profiles

30.1. Carbapenem-Based Antibiotics Market Competitive Landscape

30.2. Carbapenem-Based Antibiotics Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Fresenius Kabi LLC Overview, Products and Services, Strategy and Financial Analysis

30.2.4. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Carbapenem-Based Antibiotics Market Other Major And Innovative Companies

31.1. Teva Pharmaceutical Industries Ltd.

31.2. AstraZeneca plc

31.3. Meiji Holdings Co. Ltd.

31.4. Sandoz International GmbH

31.5. Sumitomo Dainippon Pharma Co. Ltd.

31.6. Shionogi & Co Ltd.

31.7. Aurobindo Pharma Ltd.

31.8. Acurx Pharmaceuticals LLC

31.9. Daewoong Pharmaceutical Co. Ltd.

31.10. CeramTec GmbH

31.11. ACS Dobfar S.p.A

31.12. JW Pharmaceutical Corp

31.13. Centrient Pharmaceuticals Co

31.14. Spero Therapeutics Inc.

31.15. Kopran Limited

32. Global Carbapenem-Based Antibiotics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Carbapenem-Based Antibiotics Market

34. Recent Developments In The Carbapenem-Based Antibiotics Market

35. Carbapenem-Based Antibiotics Market High Potential Countries, Segments and Strategies

35.1 Carbapenem-Based Antibiotics Market In 2029 - Countries Offering Most New Opportunities

35.2 Carbapenem-Based Antibiotics Market In 2029 - Segments Offering Most New Opportunities

35.3 Carbapenem-Based Antibiotics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Carbapenem-Based Antibiotics Market, Sub-Segmentation Of Meropenem, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Carbapenem-Based Antibiotics Market, Sub-Segmentation Of Imipenem, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Carbapenem-Based Antibiotics Market, Sub-Segmentation Of Doripenem, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Carbapenem-Based Antibiotics Market, Sub-Segmentation Of Tebipenem, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Carbapenem-Based Antibiotics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Carbapenem-Based Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Carbapenem-Based Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Pfizer Inc. Financial Performance
  • Table 80: Merck & Co. Inc. Financial Performance
  • Table 81: Fresenius Kabi LLC Financial Performance
  • Table 82: GlaxoSmithKline Plc Financial Performance
  • Table 83: Eli Lilly and Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Carbapenem-Based Antibiotics Market, Sub-Segmentation Of Meropenem, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Carbapenem-Based Antibiotics Market, Sub-Segmentation Of Imipenem, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Carbapenem-Based Antibiotics Market, Sub-Segmentation Of Doripenem, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Carbapenem-Based Antibiotics Market, Sub-Segmentation Of Tebipenem, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Carbapenem-Based Antibiotics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Carbapenem-Based Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Carbapenem-Based Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Carbapenem-Based Antibiotics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Carbapenem-Based Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Carbapenem-Based Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Pfizer Inc. Financial Performance
  • Figure 80: Merck & Co. Inc. Financial Performance
  • Figure 81: Fresenius Kabi LLC Financial Performance
  • Figure 82: GlaxoSmithKline Plc Financial Performance
  • Figure 83: Eli Lilly and Company Financial Performance

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Read More About Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Read More About Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Read More About Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Read More About Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Carbapenem-Based Antibiotics Global Market Report 2025 – By Type (Meropenem, Imipenem, Doripenem, Tebipenem, Other Types), By Indication (Intra-abdominal Infections, Urinary Tract Infections, Pneumonia, Bacterial Meningi...

View Report

Macrolide Antibiotics Global Market Report 2025 – By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, Telithromycin), By Indication (Respiratory Tract Infections, Skin Infections, Sexually Transmitted Infe...

View Report

Antibiotics Global Market Report 2025 – By Drug Class (Penicillin, Cephalosporin, Aminoglycosides, Tetracycline, Macrolides, Fluoroquinolones, Sulfonamides, Other Classes), By Spectrum Of Activity (Broad-spectrum Antibio...

View Report

Animal Antibiotics and Antimicrobials Global Market Report 2025 – By Type of Product (Tetracyclines, Penicillins, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins, Other Antimicro...

View Report

Peptide Antibiotics Global Market Report 2025 – By Type (Ribosomal Synthesized Peptide Antibiotics, Non-ribosomal Synthesized Peptide Antibiotics), By Drugs (Daptomycin, Dalbavancin, Telavancin, Other Drugs), By Disease ...

View Report

Glycopeptide Antibiotics Global Market Report 2025 – By Drug (Vancomycin, Dalbavancin, Oritavancin, Other Drugs), By Route of Administration (Oral, Parenteral, Other Routes), By Indication (Skin And Structure Infection, ...

View Report

Multidrug Resistant Bacteria Global Market Report 2025 – By Disease (Urinary Tract Infection, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, Acute Bacterial Skin And Skin Structure...

View Report

Veterinary Antibiotics Global Market Report 2025 – By Product (Anti-parasitic, Anti-bacterial, Non-steroidal anti-inflammatory drug, Others), By End User (Farm Animals , Companion Animals), By Administration (Premixes, I...

View Report

Frequently Asked Questions

Carbapenem-based antibiotics are a class of broad-spectrum antibiotics that are highly effective against many bacterial infections. Carbapenem antibiotics are commonly used to treat severe infections caused by gram-positive and gram-negative bacteria, including some strains resistant to other antibiotics. For further insights on this market, request a sample here

The market major growth driver - Rising Bacterial Infections And The Surge In Demand For Carbapenem-Based Antibiotics Is A Driving Force In Market Expansion. For further insights on this market, request a sample here

The carbapenem-based antibiotics market size has grown steadily in recent years. It will grow from $4.6 billion in 2024 to $4.78 billion in 2025 at a compound annual growth rate (CAGR) of 3.8%. The growth in the historic period can be attributed to epidemics and pandemics, rise in chronic diseases, healthcare infrastructure growth, rapid urbanization, natural disasters and health emergencies The carbapenem-based antibiotics market size is expected to see strong growth in the next few years. It will grow to " $5.97 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increased incidence of hospital-acquired infections, emergence of multi-drug resistant strains, growing aging population, rise in surgical procedures, proliferation of infectious diseases, changing demographics. Major trends in the forecast period include supply chain resilience and security, alternative treatment development, shift towards outpatient settings, growing awareness on antimicrobial stewardship, precision medicine approaches. For further insights on this market, request a sample here

The carbapenem-based antibiotics market covered in this report is segmented –
1) By Type: Meropenem, Imipenem, Doripenem, Tebipenem, Other Types
2) By Indication: Intra-abdominal Infections, Urinary Tract Infections, Pneumonia, Bacterial Meningitis, Skin And Skin Structure Infections, Acute Pelvic Infections, Prophylaxis of Surgical Site Infection, Respiratory Tract Infections, Gynecological Infections, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments:
1) By Meropenem: Meropenem Injection, Meropenem and Vaborbactam Combination, Meropenem for Pediatric Use
2) By Imipenem: Imipenem and Cilastatin Combination, Imipenem and Relebactam Combination, Imipenem Monotherapy
3) By Doripenem: Doripenem Injection, Doripenem for Complicated Infections
4) By Tebipenem: Tebipenem for Oral Administration, Tebipenem Pediatric Formulations, Tebipenem for Resistant Infections
5) By Other Types: Ertapenem, Panipenem, Faropenem, Combinations with Beta-Lactamase Inhibitors For further insights on this market, request a sample here

North America was the largest region in the Carbapenem-Based Antibiotics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the carbapenem-based antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the carbapenem-based antibiotics market include Pfizer Inc., Merck & Co. Inc., Fresenius Kabi LLC, GlaxoSmithKline Plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Meiji Holdings Co. Ltd., Sandoz International GmbH, Sumitomo Dainippon Pharma Co. Ltd., Shionogi & Co Ltd., Aurobindo Pharma Ltd., Acurx Pharmaceuticals LLC, Daewoong Pharmaceutical Co. Ltd., CeramTec GmbH, ACS Dobfar S.p.A, JW Pharmaceutical Corp, Centrient Pharmaceuticals Co, Spero Therapeutics Inc., Kopran Limited, Savior Lifetec Corporation, Flagship Biotech International Pvt. Ltd., Iterum Therapeutics plc, Cam Carbapenem-based antibiotics BV, Intelicure Lifesciences, Ikeda Corporation . For further insights on this market, request a sample here.

Major trends in this market include Innovative Product Launches Drive Growth In The Carbapenem-Based Antibiotics Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Carbapenem-Based Antibiotics Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon